Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential BCG and Electromotive Mitomycin-C vs BCG Alone for High Risk Superficial Bladder Cancer
NCT01442519Phase 3Completed
- Sponsor
- University of Rome Tor Vergata
- Start
- Jan 1994
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c in bladder cancer, sponsored by University of Rome Tor Vergata. Started Jan 1994; status: completed.
02
Drugs
mitomycin c
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01442519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442519.